525 E 68th St# M404New York, NY 10065
Fax+1 646-962-0203
Overview of Dr. Villena-Vargas
Dr. Jonathan Villena-Vargas is a thoracic surgeon in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, New York-Presbyterian Hospital, New York-Presbyterian Hospital, NewYork-Presbyterian Brooklyn Methodist Hospital, New York-Presbyterian Queens, NewYork-Presbyterian/Columbia University Irving Medical Center, and Mount Sinai Beth Israel. He received his medical degree from Loma Linda University School of Medicine and has been in practice 8 years. He is one of 30 doctors at Mount Sinai Beth Israel and one of 147 doctors at New York-Presbyterian Hospital who specialize in Thoracic Surgery. He also speaks multiple languages, including Spanish and Portuguese. He has more than 30 publications and over 500 citings.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Thoracic Surgery - Independent, 2017 - 2019
Icahn School of Medicine at Mount Sinai (Beth Israel)Residency, Surgery, 2009 - 2017
Memorial Sloan Kettering Cancer CenterFellowship, Immunology/Oncology Research Fellowship, 2011 - 2014
Loma Linda University School of MedicineClass of 2009
Certifications & Licensure
NY State Medical License 2019 - 2026
American Board of Thoracic Surgery Thoracic and Cardiac Surgery
Publications & Presentations
PubMed
- Does High Standard Uptake Value on Positron Emission Tomography Preclude Sublobar Resection in Stage IA Non-Small Cell Lung Cancer ≤2 cm?Shaikha Al-Thani, Abu Nasar, Jonathan Villena-Vargas, Oliver Chow, Sebron Harrison
The Annals of Thoracic Surgery. 2025-05-01 - All segments are created equal: locoregional recurrence and survival after single versus multi-segment resection in patients with clinical stage IA ≤2 cm non-small-cel...Shaikha Al-Thani, Abu Nasar, Jonathan Villena-Vargas, Sebron Harrison, Benjamin Lee
European Journal of Cardio-Thoracic Surgery. 2025-03-04 - Should sampling of three N2 stations be a quality metric for curative resection of stage I lung cancer?Shaikha Al-Thani, Abu Nasar, Jonathan Villena-Vargas, Oliver Chow, Benjamin Lee
The Journal of Thoracic and Cardiovascular Surgery. 2024-11-01
Press Mentions
Late-Stage Cancer Diagnoses Rise After Pandemic-Related Drop in ScreeningsJuly 25th, 2022- Surgical Resection After Neoadjuvant Durvalumab and Radiation Is Feasible and Safe in Non-Small Cell Lung Cancer: Results from a Randomized TrialMay 17th, 2022
Other Languages
- Spanish, Portuguese
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
